Peyton Williams
Story Poster
314:21
SECMD26: Georgia, Auburn, Vandy & South Carolina take on Tuesday
1 mo ago by TexAgs
Tuesday at SEC Media Days brings representatives from Georgia, Auburn, Vanderbilt and South Carolina into the spotlight. Each head coach and three player representatives for each school took to the stage on Day 2, along with SEC Coordinator of Football Officials John McDaid.
Story Poster
Tomorrow's Questions Today: Things to ask on Tuesday at SECMD26
1 mo ago by Richard Zane
On Tuesday, Auburn, Georgia, South Carolina and Vanderbilt will step into the spotlight on the second day of 2026 SEC Media Days at the Marriott Water Street in Tampa. Here's a handful of questions that might come up on Day 2 in the Sunshine State.
Story Poster
Key Matchups: No. 3 Texas A&M vs. South Carolina
9 mo ago by Olin Buchanan
No. 3 Texas A&M will play its first home game in over a month when the Aggies face South Carolina in Week 12. Ahead of Saturday's much-anticipated return to Kyle Field, Olin Buchanan details the in-game matchups that will have the greatest impact on the outcome.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
5:04
Nuño's Notes: Beamer Ball comes to College Station in Week 12
9 mo ago by David Nuño
Shane Beamer's Gamecocks have not had the success they enjoyed a year ago as the garnet and black are sitting at 3-6 overall and are in jeopardy of not making the postseason. Prior to Saturday's game in Aggieland, David Nuño shares some intel gathered from Columbia insiders.
Story Poster
23:33
Series Preview: Texas A&M at the Frisco College Baseball Classic
4 yr ago by David Sandhop
Texas A&M returns to the Frisco Classic this weekend for the third time in program history, but it will be Jim Schlossnagle's first trip to Rider's Field at the helm. The three-game, round-robin tournament will see the Aggies face Washington State, Iowa and Wichita State.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.